Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.Travel Med Infect Dis. 2020 Sep-Oct; 37:101678.TM
Links
MeSH
Pub Type(s)
Letter
Comment
Language
eng
PubMed ID
32325121
Citation
Ortiz-Martínez, Yeimer. "Tocilizumab: a New Opportunity in the Possible Therapeutic Arsenal Against COVID-19." Travel Medicine and Infectious Disease, vol. 37, 2020, p. 101678.
Ortiz-Martínez Y. Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19. Travel Med Infect Dis. 2020;37:101678.
Ortiz-Martínez, Y. (2020). Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19. Travel Medicine and Infectious Disease, 37, 101678. https://doi.org/10.1016/j.tmaid.2020.101678
Ortiz-Martínez Y. Tocilizumab: a New Opportunity in the Possible Therapeutic Arsenal Against COVID-19. Travel Med Infect Dis. 2020;37:101678. PubMed PMID: 32325121.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
A1 - Ortiz-Martínez,Yeimer,
Y1 - 2020/04/20/
PY - 2020/4/4/received
PY - 2020/4/15/accepted
PY - 2020/4/24/pubmed
PY - 2020/10/27/medline
PY - 2020/4/24/entrez
KW - COVID-19
KW - Coronavirus
KW - IL-6
KW - SARS-CoV-2
KW - Tocilizumab
SP - 101678
EP - 101678
JF - Travel medicine and infectious disease
JO - Travel Med Infect Dis
VL - 37
SN - 1873-0442
UR - https://www.unboundmedicine.com/medline/citation/32325121/Tocilizumab:_A_new_opportunity_in_the_possible_therapeutic_arsenal_against_COVID_19_
DB - PRIME
DP - Unbound Medicine
ER -